The PEGS conference provides you with updates on the most recent advancements in the respective fields – from protein engineering to cell line development. Make sure to stop by the digital Svar Booth while exploring the digital event.
Learn more about our exiting products and services that can help streamline your drug development and gene therapy projects!
Like many of you, we have been closely following updates and guidances from local, national and global agencies for COVID-19. We have made the decision to postpone many of our in-person events to next year. But we will attend PEGS Boston Summit as a virtual meeting instead of an in-person event for this year.
We are very excited to announce that we will be hosting a scientific talk: "Quantification of the Immune Response to AAV Mediated Gene Therapy" presented by Michael G. Tovey, Ph.D - Managing Director, Svar Life Science, France.
A highly sensitive iLite® reporter assay based on the establishment of a cell line stably transfected with a luciferase reporter-gene placed under the control of an AAV-responsive chimeric promoter, provides a highly sensitive, rapid and precise method for quantifying the immune response to a wide range of recombinant AAV vectors.